PHRM — Pharmather Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- CA$5.01m
- CA$4.08m
Annual cashflow statement for Pharmather Holdings, fiscal year end - May 31st, CAD millions except per share, conversion factor applied.
2022 May 31st | 2023 May 31st | 2024 May 31st | 2025 May 31st | 2026 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.01 | -6.42 | -3.12 | -1.53 | -0.61 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.507 | 2.63 | 0.215 | 0.18 | -0.025 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.176 | 0.546 | -0.622 | 0.136 | 0.151 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -3.51 | -3.24 | -3.52 | -1.21 | -0.485 |
| Capital Expenditures | 0 | — | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | -0.3 | 0 | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | -0.3 | 0 | — |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 9.89 | 0 | 0.035 | 0 | 0.25 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.38 | -3.24 | -3.79 | -1.21 | -0.235 |